Wissenschaftliche Arbeiten

Dr. Nilay Akagün

17 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Real-World Comparison of the Effectiveness of Defocus Incorporated Multiple Segments and Myopi-X Spectacle Lenses for Myopia Control in Turkish Children: A Retrospective Study

    Turkish Journal of Ophthalmology, 2026

    DOI 10.4274/tjo.galenos.2026.23529 PMID 41705844 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  2. Real-World Effectiveness of CARE-Based Spectacle Lenses for Myopia Control in a Turkish Pediatric Cohort

    Vision, 2026

    DOI 10.3390/vision10020019 PMID 42029483 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  3. Defocus incorporated multiple segments spectacle lenses for myopia control: A retrospective study in a Turkish cohort

    Ophthalmic and Physiological Optics, 2025

    DOI 10.1111/opo.13527 PMID 40391579 2 Zitationen (Europe PMC) Quelle: OpenAlex

  4. Evaluation of Reasons for Discontinuation of Atropine 0.01% in Myopia Management: A Single-Center Retrospective Study from Türkiye

    Turkish Journal of Ophthalmology, 2025

    DOI 10.4274/tjo.galenos.2025.86584 PMID 40272076 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  5. Myopi-X lenses vs. low-dose atropine in myopia control: a Turkish retrospective study

    BMC Ophthalmology, 2025

    DOI 10.1186/s12886-025-04009-8 PMID 40247228 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Combination Therapy with Atropine 0.05% and Myopi-X® Glasses: Is it Effective in Myopia Control?

    Turkish Journal of Ophthalmology, 2025

    DOI 10.4274/tjo.galenos.2024.17971 PMID 39905978 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  7. Real-World Effectiveness of DIMS Spectacle Lenses for Myopia Control in a Turkish Pediatric Population: A Retrospective Study Using Age-Specific Physiological Growth Curves

    Children, 2025

    DOI 10.3390/children12111435 PMID 41300553 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  8. Long-Term Use of Blue Light-Filtering Glasses and Symptom Improvement in Digital Eye Strain: A Questionnaire-Based Study

    Cureus, 2025

    DOI 10.7759/cureus.98003 PMID 41322997 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Evaluating combination therapies for myopia control: Insights from a retrospective study‐combining atropine %0.05 with peripheric defocus progressive addition lenses

    Acta Ophthalmologica, 2025

    DOI 10.1111/aos.17172 Quelle: OpenAlex

  10. Evaluating combination therapies for myopia control: Insights from a retrospective study‐combining atropine %0.05 with peripheric defocus progressive addition lenses

    Acta Ophthalmologica, 2025

    DOI 10.1111/aos.17005 Quelle: OpenAlex

  11. Myopi‐X spectacle lenses vs atropine 0.01% for myopia control: Turkish study

    Acta Ophthalmologica, 2025

    DOI 10.1111/aos.17009 Quelle: OpenAlex

  12. Myopi‐X spectacle lenses vs atropine 0.01% for myopia control: Turkish study

    Acta Ophthalmologica, 2025

    DOI 10.1111/aos.17176 Quelle: OpenAlex

  13. Simple surgical approach for treatment of ankyloblepharon filiforme adnatum

    Nigerian Journal of Clinical Practice, 2022

    DOI 10.4103/njcp.njcp_571_20 PMID 35170449 1 Zitation (Europe PMC) Quelle: OpenAlex

  14. Rapid healing of a persistent corneal epithelial defect (PCED) with autologous serum treatment

    Nigerian Journal of Clinical Practice, 2020

    DOI 10.4103/njcp.njcp_172_19 PMID 31929219 3 Zitationen (Europe PMC) Quelle: OpenAlex

  15. Treatment of Recurrent Corneal Erosion Syndrome with Autologous Serum Eye Drops.

    Quelle: Profilseite auf acibadem.com.tr

  16. Persistent Accommodative Spasm.

    Quelle: Profilseite auf acibadem.com.tr

  17. Creutzfeldt-Jakob Disease presenting with visual signs: A case report.

    Quelle: Profilseite auf acibadem.com.tr